Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
We break down Nobl SDY fees, showing which charges eat into profits and how to minimize them through smarter selection and timing of trades.
20,285 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
AI stocks have pulled back, but the fundamental machine beneath the hype is still growing. Learn why forget sell-off:...
SK Hynix's $29 billion ADR listing becomes a live test of whether the memory cycle can endure. Markets will parse dem...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
A new federal lawsuit alleges that U.S. immigration agencies shared confidential information about Iranian asylum see...
A major tech firm is aggressively buying back shares while insiders pile in. This article breaks down what it signals...
Cathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
A major broker cuts Alibaba's target to $170 after a sharp drop in Q3 profits, driven by heavy AI investment. The clo...
Prediction markets surged amid the 2026 World Cup, with Polymarket's World Cup market approaching $4 billion as tech ...
Megapot has secured $5 million in a Dragonfly-led round to scale a crypto-powered global lottery. The platform now se...
From repeated loan denials to a growing 10+ unit multifamily portfolio, this deal diary-style story reveals the strat...
Tech shares wobble as regulatory headlines hit the tape. This piece breaks down the Snap slump, regulatory risks from...